China Germany Night

Date: Friday, April 19, 2024
Time: 6:45 PM to 8:30 PM


Sponsored by:


2024 OARSI China-Germany Night

Welcome to submit 3-minutes speech abstracts!

1. Background of the Meeting

Osteoarthritis Research Society International (OARSI) is the premier international organization for scientists and health care professionals focusing on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education, and the worldwide dissemination of new knowledge. Professors Changhai Ding, Chunyi Wen, Madry Henning, and Magali Cucchiarini are delighted to host the "OARSI China-Germany Night” meeting session umbrellaed in the OARSI 2024 World Conference. They extend a warm invitation to accomplished experts and emerging young researchers to join this gathering, aimed at fostering collaborations and discussing the latest developments in osteoarthritis research. This event seeks to unite researchers from both countries and beyond to explore opportunities for collaboration and advancement in the field.

OARSI China-Germany Night will be held in Vienna, Austria on April 19th, 2024. Prof. Jianhao Lin (Director of Department of Arthritis Clinic and Research Center at People’s Hospital, Peking University), and Prof. Yuqing Zhang (President of the International Chinese Osteoarthritis Research Society) will serve as the meeting’s honorary chairs. Prof. Changhai Ding (OARSI National Ambassador for China, and Director of Clinical Research Center at Zhujiang Hospital of Southern Medical University), Prof. Chunyi Wen (OARSI Board Member, Department of Biomedical Engineering, The Hongkong Polytechnic University), Prof. Madry Henning (Editor-in-Chief of O&C Open, Director of the Department of Orthopaedic Surgery at Saarland University), and Prof. Magali Cucchiarini (Chair of Orthopaedic Research and Director of the Center of Experimental Orthopaedics at Saarland University) will be the chairs of this meeting. 

The meeting will specially invite world-renowned experts to discuss research progress of osteoarthritis in 2023. Meanwhile, a 3-minutes speech contest will be held for outstanding young researchers, and prizes will be provided to the winners selected by the meeting committee. This event is sponsored by Hunan Jiudian Pharmaceutical Co., Ltd and Research and Innovation Office, Hong Kong Polytechnic University. We sincerely invite you to participate in this event.

2. Organizational Structure

Honorary Chairs: Jianhao Lin, and Yuqing Zhang

Chair: Changhai Ding, Chunyi Wen, Henning Madry, and Magali Cucchiarini

Organization Committee Members:Danny Chan, Barbara Chan, Xinzhan Mao, Hua Tian, etc. 

Committee Secretaries: Su’an Tang, Zhiqiang Wang, Tianshu Jiang, and Justin Chan


3. Main Speakers 

Special Invited Experts:(20mins)


3-Minutes Speeches by 10 Outstanding Young Researchers 


1. Doctoral students or postdoctoral fellows, <35 years old;

2. Engaged in osteoarthritis research;

3. Please submit your abstracts to the email address: before 10 March for selection. 

4. Expert Profiles

Honorary Chairs

Jianhao Lin

Director, Department of Arthritis Clinic and Research Center at People’s Hospital, Peking University. Prof. Lin was a Board Member and the Chairman of Asian Task of Osteoarthritis Research Society International (OARSI). He is one of founders of International Chinese Osteoarthritis Research Society (ICOARS). His expertise includes evaluation of the disorders of the joint, particularly the lower extremity joints, extensive experience in total hip and knee arthroplasty, actively involved in a population-based survey of knee osteoarthritis in Chinese population, with interests in the mechanics of osteoarthritis and joint reconstruction and replacement.


Yuqing Zhang 

Prof Zhang is an epidemiologist in the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital and Harvard Medical School. He is an Adjunct Professor of Medicine & Public Health at Boston University School of Medicine, Boston, MA, USA.

Dr. Zhang directs research on cancer, arthritis, osteoporosis, moderate alcohol consumption, cardiovascular disease, and cognitive function.



Changhai Ding

Dr Changhai Ding is a Professor and Director of Clinical Research Centre, Zhujiang Hospital at Southern Medical University. He is an Adjunct Professor at University of Tasmanian and Monash University, Australia, and a Specially-appointed Professor at Sun Yat-Sen University, China. Dr. Ding is Vice President of International Chinese Osteoarthritis Research Society (ICOARS), a Vice-President of Australia Chinese Association for Biomedical Sciences (ACABS), Chairman of ACABS Tasmania Branch, President of Tasmania Chinese Professionals Association, and a former Board Member of Osteoarthritis Research Society International (OARSI). He is an Associate Editor for Reviews on Recent Clinical Trials, and an Editorial Board Member for Osteoarthritis & Cartilage, Arthritis Research & Therapy, Journal of Orthopaedic Translation and other 7 international journals. He is a regular peer reviewer for > 30 international journals including Lancet, JAMA and BMJ. He has received many awards including Australia Research Council Future Fellowship (2012) and NHMRC Early Career Award (2009). Prof Ding has focused on the epidemiological and clinical studies in osteoarthritis and osteoporosis. He has received grants from competitive sources totally over 7 million Australian dollars, and has published over 310 manuscripts in international peer-reviewed journals including JAMA, JAMA Internal Medicine, Annals of Internal Medicine, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Science Translational Medicine, Blood, and Osteoarthritis & Cartilage.


Chunyi Wen


Dr. Chunyi WEN, Associate Professor in Department of Biomedical Engineering at the Hong Kong Polytechnic University, leads a research group in Hong Kong to combat osteoarthritis, a leading cause of chronic pain and disability in older adults affecting 500 million people worldwide. He is currently a Board Member of OARSI. Dr. Wen obtained his Ph.D. degree in Chinese University of Hong Kong and received postgraduate training in Johns Hopkins University in U.S., and University of Oxford in U.K. In his early academic career, Dr. Wen’s work on bone and joint injury and degeneration from mechanism towards therapeutics. He contributed to discovery of TGF-beta1 as a key regulator in subchondral bone disturbance and osteoarthritis pathogenesis (Nature Medicine 2013). His work has been recognized by Young Investigator Award, Mr. Savio Woo and Mrs. Pattie Woo Travel Fellowship, AOSpine East Asia (AOSEA) Research Grant award and AOSEA Travel Grant, and Oldendorf Award. Since joining PolyU BME, Dr. Wen’s research centers on vascular etiology of osteoarthritis. Under the auspices of RGC ECS and GRF, Dr. Wen and his team finally identified endothelin-1 (ET-1), the most potent vasoconstrictor in hypertension, contributing to articular chondrocyte senescence and osteoarthritis pathology (Osteoarthritis and Cartilage 2015 and 2020). It substantiates the vascular etiology hypothesis of osteoarthritis and opens a new avenue for discovery of novel mechanism-based disease-modifying therapies against osteoarthritis (Nature Review Rheumatology 2021). Along this research direction, Dr. Wen has secured the external research fund over 10 million HKD in the capacity of PI from RGC, HMRF and ITF. Meanwhile, the team kicked off formal research collaboration with world-leading research institutes such as Kennedy Institute of Rheumatology, University of Oxford (Prof. Tonia Vincent, HMRF research fellowship) and Sorbonne University in Paris (Prof. Francis Berenbaum, PROCORE-France/Hong Kong Joint Research Scheme and INSERM International Research Program). 


Henning Madry

Henning Madry is a clinician-scientist, a tenured Professor and Chair of Orthopaedic Research and Director of the Center of Experimental Orthopaedics at Saarland University in Germany. Dr. Madry received his M.D. from Humboldt University, Berlin, under the mentorship of Detlev Ganten. His postdoctoral research fellowship was at Harvard Medical School in Boston, with Steven B. Trippel at the Massachusetts General Hospital and at Massachusetts Institute of Technology in Cambridge, with Gordana Vunjak-Novakovich. Dr. Madry received calls to Professorships at the Humboldt University Berlin, the University of Regensburg and the Albert-Ludwigs-University Freiburg. He is the Founding Editor-in-Chief of the Journal of Experimental Orthopaedics, the basic science journal of the European Society for Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA). As a clinically active orthopedic surgeon, he has special expertise in regenerative treatments for cartilage defects and osteoarthritis. His research program translates novel molecular, cell biology and tissue engineering approaches into clinical applications in orthopedic surgery with a focus on translational aspects of osteochondral regeneration. Henning Madry was recently a visiting professor at the Sorbonne Université Paris in France.


Magali Cucchiarini

Magali Cucchiarini, PhD, is an Associate Professor, Group Leader, and Vice-Director of the Center of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany. She graduated from the University of Nice-Sophia Antipolis, France where she received her PhD with summa cum laude. Dr. Cucchiarini was a senior post-doctoral fellow at Harvard Medical School and worked for two years at the University Hospital Inselsspital, Bern Switzerland. Her major research interest lies in generating novel cell-, gene-, and tissue engineered-based systems to treat orthopaedic disorders. Dr. Cucchiarini made over 165 national and international presentations, co-authored 18 books chapters and edited one book (Regenerative therapy for the musculoskeletal system using recombinant adeno-associated viral vectors), and is an author of over 190 peer-reviewed articles. She sits on the Editorial Boards for OAC Open, Journal of Experimental Orthopaedics, BioMed Research International, and OJSM and serves as a reviewer for Acta Biomaterialia, AJSM, Biomaterials, Current Pharmaceutical Design, eCM, Gene Therapy, Journal of Orthopaedic Research, Molecular Therapy, Nanomedicine, Osteoarthritis Cartilage, Scientific Reports, Stem Cell Research & Therapy, Tissue Engineering. She serves as a Board Member of the OARSI, was a Board Member of the ORS and is involved at the ICRS and American Society of Gene & Cell Therapy.

Special Invited Speakers


  1. Programme

April 19th, 2024







                Opening Ceremony


Progress in clinical research of osteoarthritis in 2023


Progress in basic medical research of osteoarthritis in 2023


Progress in imaging research of osteoarthritis in 2023


3-Minutes Speech Contest 

--Outstanding Young Researchers (<35 years old)